Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Fujieda

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2025
Prognostic value of lupus anticoagulant and anti-β2 glycoprotein I antibody in adverse pregnancy outcomesMegumi Nonobe, Takahiro Otani, Hiroyuki Yoshihara, et al.
Rheumatology (Oxford, England)|December 4, 2018
Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndromeNaoki Ohnishi, Yuichiro Fujieda, Ryo Hisada, et al.
Rheumatology (Oxford, England)|September 18, 2020
Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort studyYusuke Ogata, Yuichiro Fujieda, Masanari Sugawara, et al.
Rheumatology (Oxford, England)|December 7, 2018
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosusRyo Hisada, Masaru Kato, Naoki Ohnishi, et al.
Rheumatology (Oxford, England)|January 12, 2020
Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositisKohei Karino, Michihiro Kono, Michihito Kono, et al.
Rheumatology (Oxford, England)|June 23, 2012
Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung diseaseToshio Odani, Shinsuke Yasuda, Yuko Ota, et al.
Clinical and Experimental Rheumatology|May 18, 2021
The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertensionKeita Ninagawa, Masaru Kato, Hiroshi Ohira, et al.
Rheumatology (Oxford, England)|December 2, 2022
Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot studyKeita Ninagawa, Masaru Kato, Satonori Tsuneta, et al.
Medicine|April 28, 2019
A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitisKanako Watanabe-Kusunoki, Nobuya Abe, Daigo Nakazawa, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 2, 2023
Dynamics of corticocortical brain functional connectivity relevant to therapeutic response to biologics in inflammatory arthritisKodai Sakiyama, Nobuya Abe, Yuichiro Fujieda, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2025
Prognostic value of lupus anticoagulant and anti-β2 glycoprotein I antibody in adverse pregnancy outcomesMegumi Nonobe, Takahiro Otani, Hiroyuki Yoshihara, et al.
Rheumatology (Oxford, England)|December 4, 2018
Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndromeNaoki Ohnishi, Yuichiro Fujieda, Ryo Hisada, et al.
Rheumatology (Oxford, England)|September 18, 2020
Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort studyYusuke Ogata, Yuichiro Fujieda, Masanari Sugawara, et al.
Rheumatology (Oxford, England)|December 7, 2018
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosusRyo Hisada, Masaru Kato, Naoki Ohnishi, et al.
Rheumatology (Oxford, England)|January 12, 2020
Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositisKohei Karino, Michihiro Kono, Michihito Kono, et al.
Rheumatology (Oxford, England)|June 23, 2012
Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung diseaseToshio Odani, Shinsuke Yasuda, Yuko Ota, et al.
Clinical and Experimental Rheumatology|May 18, 2021
The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertensionKeita Ninagawa, Masaru Kato, Hiroshi Ohira, et al.
Rheumatology (Oxford, England)|December 2, 2022
Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot studyKeita Ninagawa, Masaru Kato, Satonori Tsuneta, et al.
Medicine|April 28, 2019
A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitisKanako Watanabe-Kusunoki, Nobuya Abe, Daigo Nakazawa, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 2, 2023
Dynamics of corticocortical brain functional connectivity relevant to therapeutic response to biologics in inflammatory arthritisKodai Sakiyama, Nobuya Abe, Yuichiro Fujieda, et al.
Pageof 11